These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6783287)
81. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice]. Trautmann M; Brückner O; Hahn H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803 [TBL] [Abstract][Full Text] [Related]
82. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa. Johnston LJ; Syeklocha D Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185 [No Abstract] [Full Text] [Related]
83. Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge. Maria de Souza Morais S; Ferreira Rodigues N; Ingrid Oliveira da Silva N; Aparecido Salvador E; Rodrigues Franco I; Augusto Pires de Souza G; Henrique Cruvinel da Silva P; Gustavo Nogueira de Almeida L; Prado Rocha R; Carolina Toledo da Cunha Pereira A; Portela Ferreira G; Veras Quelemes P; Pereira de Araújo M; Fornias Sperandio F; Júnia de Souza Santos L; Assis Martins Filho O; Cosme Cotta Malaquias L; Felipe Leomil Coelho L Vaccine; 2018 Oct; 36(43):6408-6415. PubMed ID: 30228029 [TBL] [Abstract][Full Text] [Related]
84. Study of Pseudomonas haemolysin. III. Properties of antilysin serum. Lochmann O; Výmola F J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):224-9. PubMed ID: 809503 [TBL] [Abstract][Full Text] [Related]
85. Effects of immunization with ethanol-soluble enterobacterial common antigen on in vivo bacterial clearance and hematogenous pyelonephritis. Frentz G; Domingue G Proc Soc Exp Biol Med; 1973 Jan; 142(1):246-52. PubMed ID: 4566760 [No Abstract] [Full Text] [Related]
86. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi. Roe EA; Jones RJ Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315 [TBL] [Abstract][Full Text] [Related]
87. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4]. Nuriddinova NR; Ivanova LE; Sheremet'ev NN; Garib FIu Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697 [TBL] [Abstract][Full Text] [Related]
88. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations]. Kiseleva IA; Kandiurina VG; Timofeeva GV Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197 [TBL] [Abstract][Full Text] [Related]
90. Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice. Pierson CL; Johnson AG; Feller I Infect Immun; 1976 Jul; 14(1):168-77. PubMed ID: 820641 [TBL] [Abstract][Full Text] [Related]
91. The protective effect of Pseudomonas culture filtrates against experimental infection in mice. Tabuchi K; Diena BB J Biol Stand; 1974 Jul; 2(3):215-22. PubMed ID: 4214818 [No Abstract] [Full Text] [Related]
92. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models. Lieberman MM; Frank WJ J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388 [TBL] [Abstract][Full Text] [Related]
93. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity. Larsson P; Kaijser B; Olling S; Akerlund AS Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056 [TBL] [Abstract][Full Text] [Related]
94. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice. Sensakovic JW; Bartell PF Infect Immun; 1977 Nov; 18(2):304-9. PubMed ID: 411754 [TBL] [Abstract][Full Text] [Related]
95. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice]. Bulava GV; Ermolin GA Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845 [TBL] [Abstract][Full Text] [Related]
96. [Immunochemical analysis and protective properties of components of Pseudomonas aeruginosa mucus with different molecular weights]. Zaĭdner IG; Palkina NA; Stanislavskiĭ ES; Landsman NM Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):92-7. PubMed ID: 6791415 [TBL] [Abstract][Full Text] [Related]